Table 2.
Prevalence of dyslipidemia among cancer patients.
| N (%) | Total | Breast cancer | Endometrial cancer | Ovarian cancer | P value |
|---|---|---|---|---|---|
| Dyslipidemia | 6739 (62.8) | 4896 (61.3) | 919 (66.8) | 924 (67.5) | <0.001 |
| Elevated TC | 1719 (16.0) | 1388 (17.4) | 187 (13.6) | 144 (10.5) | <0.001 |
| Elevated TG | 1526 (14.6) | 1199 (15.0) | 236 (17.2) | 127 (9.3) | <0.001 |
| Elevated LDL-C | 780 (7.3) | 608 (7.6) | 102 (7.4) | 70 (5.1) | <0.001 |
| Decreased HDL-C | 4730 (44.1) | 3249 (40.7) | 706 (51.3) | 775 (56.6) | <0.001 |
| Elevated TC+elevated TG | 479 (4.5) | 382 (4.8) | 61 (4.4) | 36 (2.6) | 0.002 |
| Elevated TC+elevated LDL-C | 739 (6.9) | 579 (7.2) | 95 (6.9) | 65 (4.7) | 0.003 |
| Elevated TC+decreased HDL-C | 224 (2.1) | 150 (1.9) | 38 (2.8) | 36 (2.6) | 0.034 |
| Elevated TG+elevated LDL-C | 217 (2.0) | 172 (2.2) | 26 (1.9) | 19 (1.4) | 0.166 |
| Elevated TG+decreased HDL-C | 678 (6.3) | 484 (6.1) | 132 (9.6) | 62 (4.5) | <0.001 |
| Elevated LDL-C+decreased HDL-C | 126 (1.2) | 81 (1.0) | 27 (2.0) | 18 (1.3) | 0.009 |
HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglycerides.